Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 5 of 5 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/31/12
End: 06/30/22
Due: 06/30/23
Phase: N/A
Priority: Normal
Start: 04/30/13
End: 02/29/16
Due: 02/28/17
Phase: N/A
Priority: Normal
Start: 03/31/09
End: 03/31/14
Due: 03/31/15
Phase: N/A
Priority: Normal
Start: 11/30/12
End: 06/30/18
Due: 06/30/19
Phase: N/A
Priority: Normal
Start: 06/30/14
End: 06/30/24
Due: 06/30/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Post Market TRUST Study | NCT01563783 | Acessa Health, Inc. | user2@example.com | None | 2012-12-31 | 2022-06-30 | 2023-06-30 | - | - | 2025-07-14 |
| Post Market Evaluation of Acessa With TAG | NCT01842789 | Acessa Health, Inc. | user2@example.com | None | 2013-04-30 | 2016-02-29 | 2017-02-28 | - | - | 2025-07-14 |
| Laparoscopic Radiofrequency Ablation (RFA) of Symptomatic Uterine Fibroids | NCT00874029 | Acessa Health, Inc. | user2@example.com | None | 2009-03-31 | 2014-03-31 | 2015-03-31 | - | - | 2025-07-14 |
| Laparoscopic Uterine Sparing Techniques Outcomes and Reinterventions | NCT01750008 | Acessa Health, Inc. | user2@example.com | None | 2012-11-30 | 2018-06-30 | 2019-06-30 | - | - | 2025-07-14 |
| Post Market TRUST - U.S.A. Study | NCT02163525 | Acessa Health, Inc. | user2@example.com | None | 2014-06-30 | 2024-06-30 | 2025-06-30 | - | - | 2025-07-14 |